References
- Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 1991; 3 - 11; PMID: 1984929
- Starnes CO. Coley's toxins in perspective. Nature 1992; 357:11 - 2; http://dx.doi.org/10.1038/357011a0; PMID: 1574121
- Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39 - 51; http://dx.doi.org/10.1016/j.cell.2010.03.014; PMID: 20371344
- Fischer-Valuck BW, Barrilleaux BL, Phinney DG, Russell KC, Prockop DJ, O'Connor KC. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency. Biotechnol Lett 2010; 32:19 - 27; http://dx.doi.org/10.1007/s10529-009-0110-6; PMID: 19705068
- Buddingh EP, Kuijjer ML, Duim RA, Burger H, Agelopoulos K, Myklebost O, et al. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents. Clin Cancer Res 2011; 17:2110 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-10-2047; PMID: 21372215
- Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005; 23:2004 - 11; http://dx.doi.org/10.1200/JCO.2005.06.031; PMID: 15774791
- Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the Children's Oncology Group. J Clin Oncol 2008; 26:633 - 8; http://dx.doi.org/10.1200/JCO.2008.14.0095; PMID: 18235123
- Müller CR, Smeland S, Bauer HC, Saeter G, Strander H. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series. Acta Oncol 2005; 44:475 - 80; http://dx.doi.org/10.1080/02841860510029978; PMID: 16118081
- Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, et al. The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer 2010; 54:350 - 4; http://dx.doi.org/10.1002/pbc.22136; PMID: 19902521
- Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, et al. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am J Pathol 2011; 179:1157 - 70; http://dx.doi.org/10.1016/j.ajpath.2011.05.034; PMID: 21771572